You have 9 free searches left this month | for more free features.

alpha-Defensins

Showing 1 - 25 of 2,682

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Analysis of Intestinal Defensin Expression in Acute GVHD

Active, not recruiting
  • GVHD,Acute
  • +2 more
    • Freiburg, Baden-Württemberg, Germany
      Medical Center University of Freiburg
    Nov 3, 2021

    Periorbital Wrinkles Trial in San Diego (enhanced DefenAge 8-in-1 BioSerum)

    Recruiting
    • Periorbital Wrinkles
    • enhanced DefenAge 8-in-1 BioSerum
    • San Diego, California
      West Dermatology Research Center/Cosmetic Laser Dermatology
    Oct 26, 2021

    Neonatal Sepsis Trial in Milano (Preterm Infants - fed fermented formula, Preterm Infants - fed standard formula, Pre-term

    Recruiting
    • Neonatal Sepsis
    • Preterm Infants - fed fermented formula
    • +2 more
    • Milano, Italy
      Unità di Neonatologia e Terapia Intensiva Neonatale, Clinica Ma
    Jun 1, 2022

    Etiology of Eczema Herpeticum (EH)

    Completed
    • Eczema Herpeticum
      • Denver, Colorado
        National Jewish Health: Division of Pediatric Allergy and Clinic
      Jan 13, 2021

      COVID-19 Trial in Orange (ORTD-1 low dose, ORTD-1 mid dose, ORTD-1 high dose)

      Withdrawn
      • COVID-19
      • ORTD-1 low dose
      • +3 more
      • Orange, California
        UC Irvine Medical Center
      Jun 9, 2021

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

      Terminated
      • Hepatitis B, Chronic
      • Hillsborough, New Jersey
      • +11 more
      Dec 28, 2022

      Screening for Alpha Thalassemia in Healthy Volunteers

      Recruiting
      • Alpha Thalassemia
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023

        Frontal Alpha Asymmetry and Pediatric Emergence Delirium

        Not yet recruiting
        • Emergence Delirium
        • Ophthalmic surgery
        • General anesthesia
        • (no location specified)
        Apr 5, 2023

        Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)

        Recruiting
        • Alpha-1 Antitrypsin Deficiency
        • Alpha-1 Antitrypsin Genotype
        • Gainesville, Florida
          University of Florida
        Nov 2, 2022

        Allergic Bronchiolitis Trial (Serum)

        Not yet recruiting
        • Allergic Bronchiolitis
        • Serum
        • (no location specified)
        Nov 14, 2023

        Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

        Completed
        • Rheumatoid Arthritis
        • ISIS 104838
        • Birmingham, Alabama
        • +30 more
        Dec 1, 2022

        Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

        Not yet recruiting
        • Pancreatic Cancer
        • +2 more
        • DaRT seeds insertion
        • (no location specified)
        Sep 5, 2023

        Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

        Not yet recruiting
        • Pancreatic Ductal Adenocarcinoma
        • +2 more
        • (no location specified)
        Jul 28, 2023

        Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Golimumab, Placebo)

        Recruiting
        • Arthritis, Psoriatic
        • Phoenix, Arizona
        • +96 more
        Jan 17, 2023

        Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in

        Not yet recruiting
        • Brain Ischemia
        • Serum Iron
        • +7 more
        • Aswan, Egypt
          Aswan University Hospital
        Mar 7, 2023

        Stone, Urinary Trial in Hong Kong (Silodosin, Tamsulosin)

        Recruiting
        • Stone, Urinary
        • Hong Kong, Hong Kong
          Hong Kong
        Oct 3, 2022

        Kidney Transplant Trial in Canada, United States (Infliximab, Methylprednisolone, Mycophenolate Mofetil)

        Completed
        • Kidney Transplant
        • Infliximab
        • +9 more
        • Birmingham, Alabama
        • +14 more
        Jul 19, 2022

        Alpha-Thalassemia, Alpha Thalassemia Major, Alpha Thalassemia Minor Trial in San Francisco

        Recruiting
        • Alpha-Thalassemia
        • +2 more
          • San Francisco, California
            University of California San Francisco
          Oct 7, 2022

          Vestibular Function Disorder Trial in San Antonio (Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg)

          Not yet recruiting
          • Vestibular Function Disorder
          • Alpha Lipoic Acid 300mg
          • Coenzyme Q10 200mg
          • San Antonio, Texas
            University of Texas Health Science Center at San Antonio
          Jul 5, 2023

          Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)

          Recruiting
          • Ischemic Cardiomyopathy
          • Diabetes Mellitus
          • Alpha Lipoic Acid 600 MG Oral Tablet
          • Placebo Tablet
          • Damanhūr, Elbehairah, Egypt
            Damanhour Teaching Hospital, General Organization for Teaching H
          Sep 26, 2023

          Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

          Recruiting
          • Lymphomatoid Granulomatosis
          • +3 more
          • Interferon
          • Rituxan and EPOCH
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 23, 2023

          Dexmedetomidine, Propofol, Mechanical Ventilation Trial in Tanta (Dexmedetomidine, Propofol)

          Recruiting
          • Dexmedetomidine
          • +4 more
          • Tanta, El-Gharbia, Egypt
            Tanta University
          Oct 24, 2023

          European Alpha-Mannosidosis Participant

          Terminated
          • Immunodeficiency
          • +5 more
            • Aachen, Germany
            • +18 more
            Jun 10, 2022

            GVHD Trial in Hackensack (Telmisartan)

            Active, not recruiting
            • GVHD
            • Hackensack, New Jersey
              Hackensack University Medical Center
            Sep 2, 2022

            Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)

            Recruiting
            • Metabolic Associated Fatty Liver Disease
            • LUDLEV®300 mg/46.2 mg
            • Placebo
            • Mexico, Veracruz, Mexico
              Ana Delfina Cano Contreras
            Jun 12, 2023